Category - Feature

Feature

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Closely-held xNARA Biologics is reshaping the wellness industry through personalized health and wellness solutions designed to address genetic predispositions and disorders identified by analyzing individual DNA, gut...

January 9, 2024

Feature

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Closely-held Simtra BioPharma Solutions, a premier contract development and manufacturing organization with more than 65 years of sterile injectable manufacturing experience, offers world-class cGMP sterile fill/finish...

December 19, 2023

Feature

Bridging clinical trial diversity gaps and accelerating R&D in rare disease

As founder and executive chair of the non-profit Indo-US Organization for Rare Disease (IndoUSrare), Harsha Rajasimha, Ph.D., social entrepreneur, and subject matter expert in bioinformatics, data analysis, and...

December 12, 2023

Feature

Personalis developing patient-specific test for earlier cancer detection

Personalis (NASDAQ:PSNL) is developing a liquid biopsy assay designed to detect minimal residual disease (MRD) and cancer recurrence earlier than other diagnostic methods.

December 5, 2023

Feature

Gritstone bio awaits preliminary Phase 2 data for personalized neoantigen vaccine

Gritstone bio (NASDAQ:GRTS) is expecting in the first quarter of 2024 preliminary data from its Phase 2/3 study evaluating the Company's personalized neoantigen vaccine candidate for the treatment of colorectal cancer...

November 28, 2023

Feature

Upswing Health harmonizes human touch with AI-driven technology to assess MSK pain

Closely-held Upswing Health, a virtual orthopedic company, is reinventing orthopedic care delivery through its virtual orthopedic musculoskeletal symptom assessment tool and customized pain management program...

November 21, 2023

Feature

Intrinsic Medicine developing new drugs for gut-immune-brain axis disorders

Closely-held Intrinsic medicine is developing new drugs for diseases that are linked to the disordered interaction of the gut microbiome, the immune system and the nervous system.

November 14, 2023

Feature

Rainhouse’s CNC machining expertise supporting specialty medical device manufacturing

Closely-held Rainhouse Manufacturing, a company specializing in computer numerical control (CNC) machining, quality assurance, and electronic manufacturing, is working with companies to make their medical device designs...

November 7, 2023

Feature

SeaStar Medical prepares for FDA approval of device targeting treatment of pediatric acute kidney injury

SeaStar Medical (NASDAQ: ICU) expects an FDA Approval Order in the coming months for the company's Selective Cytopheretic Device (SCD) Pediatric (SCD-PED) under a humanitarian device exemption (HDE).

October 31, 2023

Feature

Hygieia – leveraging science + research + technology to revolutionize how patients manage insulin dosing

Closely-held Hygieia, a digital therapeutics company for insulin therapy, is reforming how physicians and people with type 2 diabetes manage insulin with its breakthrough proprietary mobile app, d-Nav, which...

October 24, 2023

Category - Feature

xNARA Biologics reinventing nutritional supplements through AI-based health risk scoring and microbiome testing

Simtra BioPharma Solutions leveraging more than 65 years of experience in bringing critical pharmaceutical products to market

Bridging clinical trial diversity gaps and accelerating R&D in rare disease

Personalis developing patient-specific test for earlier cancer detection

Gritstone bio awaits preliminary Phase 2 data for personalized neoantigen vaccine

Upswing Health harmonizes human touch with AI-driven technology to assess MSK pain

Intrinsic Medicine developing new drugs for gut-immune-brain axis disorders

Rainhouse’s CNC machining expertise supporting specialty medical device manufacturing

SeaStar Medical prepares for FDA approval of device targeting treatment of pediatric acute kidney injury

Hygieia – leveraging science + research + technology to revolutionize how patients manage insulin dosing

General

More